Support Measures To Be Elaborated
The possibility to finance on a repayable basis of clinical studies of drugs and medical devices for export, manufactured by Russian companies abroad, should be elaborated by the Ministry of Industry and Trade before September, 1.
By November 15 the Ministry of Health, the Ministry of Economic Development and the Ministry of Industry and Trade will have to define targets for launch of new Russian drugs and medical devices to the market in 2016-2020.
The action plan is determined in connection with instructions of Russian Premier Minister Dmitry Medvedev regarding results of a meeting of Government Commission on Import Substitution held on July 8, 2016, at the Ministry of Economic Development. Mechanisms of industry development fund will be involved in implementation.
The Ministry of Industry and Trade of the Russian Federation and Federal Antimonopoly Service will consider the possibility of specifying preferences for drugs from the Vital and Essential Drug List in the unified informational system of public purchase, as provisioned by government decrees on limitation of access to public purchase of foreign drugs.